Denosumab in Primary Hyperparathyroidism
Latest Information Update: 07 Nov 2022
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 06 Oct 2022 Status changed from completed to discontinued.
- 08 Apr 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 26 Mar 2012 New trial record